Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)

Chua, S; Smith, IE; A'Hern, RP; Coombes, GA; Hickish, TF; Robinson, AC; Laing, RW; O'Brien, MER; Ebbs, SR; Hong, A; Wardley, A; Mughal, T; Verrill, M; Dubois, D; Bliss, JM; members, of, the, TOPIC, Trial, Group

doi:10.1093/annonc/mdi276

Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Chua S, Smith IE, A'Hern RP, Coombes GA, Hickish TF, Robinson AC, Laing RW, O'Brien MER, Ebbs SR, Hong A, Wardley A, Mughal T, Verrill M, Dubois D, Bliss JM, members of the TOPIC Trial Group

Publication type: Article

Publication status: Published

Journal: Annals of Oncology

Year: 2005

Volume: 16

Issue: 9

Pages: 1435-1441

ISSN (print): 0923-7534

ISSN (electronic): 1569-8041

Publisher: Oxford University Press

URL: http://dx.doi.org/10.1093/annonc/mdi276

DOI: 10.1093/annonc/mdi276

Altmetrics

Altmetrics provided by Altmetric

ePrints

Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)

Downloads

Publication metadata

Altmetrics

Share